Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
92.61
(
1.37%
)
Bitcoin
73,457.51
(
-0.13%
)
News Focus
News Focus
Post# of 257665
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123040
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 228801

Thursday, 05/07/2020 5:06:53 PM

Thursday, May 07, 2020 5:06:53 PM

Post# of 257665
RVNC 1Q20 results—3/31/20 cash=$511M:

https://investors.revance.com/news-releases/news-release-details/revance-reports-first-quarter-2020-financial-results-provides

2020 operating cash burn is expected to be at the low end of the prior guidance range of $220-230M due to one-quarter delay (to 3Q20) in the US launch of Teoxane’s dermal fillers.

MYL’s decision whether to opt in for the Botox-biosimilar program is expected by the end of May.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today